Corticosteroid use during pregnancy and risk of orofacial clefts
Open Access
- 11 April 2011
- journal article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 183 (7), 796-804
- https://doi.org/10.1503/cmaj.101063
Abstract
Background The association between the risk of orofacial clefts in infants and the use of corticosteroids during pregnancy is unclear from the available evidence. We conducted a nationwide cohort study of all live births in Denmark over a 12-year period. Methods We collected data on all live births in Denmark from Jan. 1, 1996, to Sept. 30, 2008. We included live births for which information was available from nationwide health registries on the use of corticosteroids during pregnancy, the diagnosis of an orofacial cleft and possible confounders. Results There were 832 636 live births during the study period. Exposure to corticosteroids during the first trimester occurred in 51 973 of the pregnancies. A total of 1232 isolated orofacial clefts (i.e., cleft lip, cleft palate, or cleft lip and cleft palate) were diagnosed within the first year of life, including 84 instances in which the infant had been exposed to corticosteroids during the first trimester of pregnancy. We did not identify any statistically significant increased risk of orofacial clefts associated with the use of corticosteroids: cleft lip with or without cleft palate, prevalence odds ratio (OR) 1.05 (95% confidence interval [CI] 0.80–1.38]; cleft palate alone, prevalence OR 1.23 (95% CI 0.83–1.82). Odds ratios for risk of orofacial clefts by method of delivery (i.e., oral, inhalant, nasal spray, or dermatologic and other topicals) were consistent with the overall results of the study and did not display significant heterogeneity, although the OR for cleft lip with or without cleft palate associated with the use of dermatologic corticosteroids was 1.45 (95% CI 1.03–2.05). Interpretation Our results add to the safety information on a class of drugs commonly used during pregnancy. Our study did not show an increased risk of orofacial clefts with the use of corticosteroids during pregnancy. Indepth investigation of the pattern of association between orofacial clefts and the use of dermatologic corticosteroids during pregnancy indicated that this result did not signify a causal connection and likely arose from multiple statistical comparisons.Keywords
This publication has 33 references indexed in Scilit:
- Safety of topical corticosteroids in pregnancyPublished by Wiley ,2009
- Maternal corticosteroid use and orofacial cleftsAmerican Journal of Obstetrics and Gynecology, 2007
- Socioeconomic Status in Relation to Selected Birth Defects in a Large Multicentered US Case-Control StudyAmerican Journal of Epidemiology, 2007
- Drug Treatment during Pregnancy and Isolated Orofacial Clefts in HungaryThe Cleft Palate Craniofacial Journal, 2007
- Oral clefts and life style factors — A case-cohort study based on prospective Danish dataEuropean Journal of Epidemiology, 2007
- Maternal diseases and isolated orofacial clefts in HungaryBirth Defects Research Part A: Clinical and Molecular Teratology, 2005
- First trimester exposure to corticosteroids and oral cleftsBirth Defects Research Part A: Clinical and Molecular Teratology, 2003
- Maternal Drug Use and Infant Cleft Lip/Palate with Special Reference to CorticoidsThe Cleft Palate Craniofacial Journal, 2003
- Case‐control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancyAmerican Journal of Medical Genetics Part A, 2003
- Associations Between Oral Clefts and Drugs Taken During PregnancyInternational Journal of Epidemiology, 1975